Anxiolytic agents with reduced sedative and ataxic effects

Organic compounds -- part of the class 532-570 series – Organic compounds – Unsubstituted hydrocarbyl chain between the ring and the -c-...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

Reexamination Certificate

active

11458739

ABSTRACT:
Orally active benzodiazepine derivatives and their salts are disclosed. These compounds and their salts have anxiolytic and anticonvulsant activity with reduced sedative/hypnotic/muscle relaxant/ataxic effects.

REFERENCES:
patent: 4401597 (1983-08-01), Walser et al.
patent: 4440685 (1984-04-01), Walser et al.
patent: 4900729 (1990-02-01), Stransky et al.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Anxiolytic agents with reduced sedative and ataxic effects does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Anxiolytic agents with reduced sedative and ataxic effects, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anxiolytic agents with reduced sedative and ataxic effects will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3833760

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.